Tarsus Pharmaceuticals, Inc. earnings per share and revenue

TARS earnings per share for the last quarter are -1.01 USD whereas the estimation was -1.18 USD which accounts for 14.47% surprise. Company revenue for the same period amounts to 27.61 M USD despite the estimated figure of 17.89 M USD. Estimated earnings per share for the next quarter are -0.93 USD, and revenue is expected to reach 31.55 M USD. Also watch annual changes over time to get a bigger picture of TARS earnings per share and revenue dynamics.